Maria‐Luisa Schubert

2.4k total citations · 1 hit paper
40 papers, 1.2k citations indexed

About

Maria‐Luisa Schubert is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Maria‐Luisa Schubert has authored 40 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 17 papers in Genetics and 12 papers in Molecular Biology. Recurrent topics in Maria‐Luisa Schubert's work include CAR-T cell therapy research (37 papers), Virus-based gene therapy research (17 papers) and Viral Infectious Diseases and Gene Expression in Insects (10 papers). Maria‐Luisa Schubert is often cited by papers focused on CAR-T cell therapy research (37 papers), Virus-based gene therapy research (17 papers) and Viral Infectious Diseases and Gene Expression in Insects (10 papers). Maria‐Luisa Schubert collaborates with scholars based in Germany, China and Japan. Maria‐Luisa Schubert's co-authors include Michael Schmitt, Carsten Müller‐Tidow, Peter Dreger, Karin Jordan, Carlos A. Ramos, Anita Schmitt, Brigitte Neuber, Lei Wang, Leopold Sellner and Susanne Hofmann and has published in prestigious journals such as Blood, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Maria‐Luisa Schubert

40 papers receiving 1.2k citations

Hit Papers

Side-effect management of chimeric antigen receptor (CAR)... 2020 2026 2022 2024 2020 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Side-effect management of chimeric antigen receptor (CAR) T-cell therapy
    2020 340 citations Maria‐Luisa Schubert, Michael Schmitt et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria‐Luisa Schubert Germany 20 1.0k 397 339 335 291 40 1.2k
Yongxian Hu China 21 1.1k 1.1× 475 1.2× 324 1.0× 353 1.1× 261 0.9× 119 1.4k
Haruko Tashiro Japan 13 1.3k 1.2× 477 1.2× 449 1.3× 536 1.6× 362 1.2× 57 1.6k
Peihua Lu China 18 1.2k 1.1× 380 1.0× 356 1.1× 553 1.7× 229 0.8× 74 1.6k
Colleen Callahan United States 16 948 0.9× 212 0.5× 299 0.9× 227 0.7× 218 0.7× 33 1.1k
Anthony F. Daniyan United States 12 784 0.8× 326 0.8× 237 0.7× 363 1.1× 241 0.8× 24 1.0k
Quanshun Wang China 10 755 0.7× 285 0.7× 241 0.7× 245 0.7× 157 0.5× 63 1.0k
Margherita Norelli Italy 6 1.2k 1.1× 388 1.0× 352 1.0× 458 1.4× 395 1.4× 9 1.5k
Corinne Summers United States 15 1.3k 1.3× 319 0.8× 411 1.2× 253 0.8× 343 1.2× 42 1.5k
Reona Sakemura United States 13 717 0.7× 249 0.6× 227 0.7× 261 0.8× 261 0.9× 54 879
Christopher Brown United States 12 1000 1.0× 248 0.6× 319 0.9× 197 0.6× 287 1.0× 20 1.1k

Countries citing papers authored by Maria‐Luisa Schubert

Since Specialization
Citations

This map shows the geographic impact of Maria‐Luisa Schubert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria‐Luisa Schubert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria‐Luisa Schubert more than expected).

Fields of papers citing papers by Maria‐Luisa Schubert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria‐Luisa Schubert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria‐Luisa Schubert. The network helps show where Maria‐Luisa Schubert may publish in the future.

Co-authorship network of co-authors of Maria‐Luisa Schubert

This figure shows the co-authorship network connecting the top 25 collaborators of Maria‐Luisa Schubert. A scholar is included among the top collaborators of Maria‐Luisa Schubert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria‐Luisa Schubert. Maria‐Luisa Schubert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schubert, Maria‐Luisa, Peter Dreger, Anita Schmitt, et al.. (2024). Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia: a phase 1/2 study. Leukemia. 38(11). 2419–2428. 18 indexed citations
2.
Wang, Lei, Brigitte Neuber, Angela Hückelhoven‐Krauss, et al.. (2024). Extracorporeal photopheresis as a promising strategy for the treatment of graft-versus-host disease after CAR T-cell therapy. Blood Advances. 8(11). 2675–2690. 3 indexed citations
3.
Schubert, Maria‐Luisa, Wolfgang Bethge, Francis Ayuk, et al.. (2023). Outcomes of axicabtagene ciloleucel in PMBCL compare favorably with those in DLBCL: a GLA/DRST registry study. Blood Advances. 7(20). 6191–6195. 9 indexed citations
4.
Schubert, Maria‐Luisa, Carolina Berger, Alexander Kunz, et al.. (2022). Comparison of single copy gene‑based duplex quantitative PCR and digital droplet PCR for monitoring of expansion of CD19‑directed CAR T cells in treated patients. International Journal of Oncology. 60(5). 9 indexed citations
5.
Gong, Wenjie, Lei Wang, Maria‐Luisa Schubert, et al.. (2022). HDAC Inhibition for Optimized Cellular Immunotherapy of NY-ESO-1-Positive Soft Tissue Sarcoma. Biomedicines. 10(2). 373–373. 4 indexed citations
6.
Gong, Wenjie, Lei Wang, Sophia Stock, et al.. (2021). Evaluation of Production Protocols for the Generation of NY-ESO-1-Specific T Cells. Cells. 10(1). 152–152. 4 indexed citations
7.
8.
Liu, Yi, Sanmei Wang, Maria‐Luisa Schubert, et al.. (2021). CD33‐directed immunotherapy with third‐generation chimeric antigen receptor T cells and gemtuzumab ozogamicin in intact and CD33‐edited acute myeloid leukemia and hematopoietic stem and progenitor cells. International Journal of Cancer. 150(7). 1141–1155. 35 indexed citations
9.
10.
Sellner, Leopold, Nicola Giesen, Maria‐Luisa Schubert, et al.. (2020). B‐cell maturation antigen‐specific chimeric antigen receptor T cells for multiple myeloma: Clinical experience and future perspectives. International Journal of Cancer. 147(8). 2029–2041. 9 indexed citations
11.
Yoo, Keun-Young, Sophia Stock, Lei Wang, et al.. (2020). Ibrutinib for improved chimeric antigen receptor T‐cell production for chronic lymphocytic leukemia patients. International Journal of Cancer. 148(2). 419–428. 52 indexed citations
12.
Schubert, Maria‐Luisa, Alexander Kunz, Anita Schmitt, et al.. (2020). Assessment of CAR T Cell Frequencies in Axicabtagene Ciloleucel and Tisagenlecleucel Patients Using Duplex Quantitative PCR. Cancers. 12(10). 2820–2820. 14 indexed citations
13.
Kunz, Alexander, Ulrike Gern, Anita Schmitt, et al.. (2020). Optimized Assessment of qPCR-Based Vector Copy Numbers as a Safety Parameter for GMP-Grade CAR T Cells and Monitoring of Frequency in Patients. Molecular Therapy — Methods & Clinical Development. 17. 448–454. 28 indexed citations
14.
Schubert, Maria‐Luisa, Sascha Dietrich, Stephan Stilgenbauer, et al.. (2020). Feasibility and Safety of CD19 Chimeric Antigen Receptor T Cell Treatment for B Cell Lymphoma Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 26(9). 1575–1580. 24 indexed citations
15.
Yang, Mingya, Lei Wang, Ming Ni, et al.. (2020). Pre-sensitization of Malignant B Cells Through Venetoclax Significantly Improves the Cytotoxic Efficacy of CD19.CAR-T Cells. Frontiers in Immunology. 11. 608167–608167. 32 indexed citations
16.
Blumenberg, Viktoria, Maria‐Luisa Schubert, Eli Zamir, et al.. (2020). Antibiotic Therapy and Low Gut Microbiome Diversity Is Associated with Decreased Response and High Toxicity in BCP-ALL and DLBCL Patients after Treatment with CD19. CAR T-Cells. Blood. 136(Supplement 1). 33–34. 13 indexed citations
17.
Yoo, Keun-Young, Yibin Liu, Lei Wang, et al.. (2019). Tumor-Specific Reactive Oxygen Species Accelerators Improve Chimeric Antigen Receptor T Cell Therapy in B Cell Malignancies. International Journal of Molecular Sciences. 20(10). 2469–2469. 15 indexed citations
18.
Wang, Lei, Wenjie Gong, Sanmei Wang, et al.. (2019). Improvement of in vitro potency assays by a resting step for clinical-grade chimeric antigen receptor engineered T cells. Cytotherapy. 21(5). 566–578. 17 indexed citations
19.
20.
Stock, Sophia, Jean‐Marc Hoffmann, Maria‐Luisa Schubert, et al.. (2018). Influence of Retronectin-Mediated T-Cell Activation on Expansion and Phenotype of CD19-Specific Chimeric Antigen Receptor T Cells. Human Gene Therapy. 29(10). 1167–1182. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yongxian Hu Breakdown of academic impact, for papers by Haruko Tashiro Breakdown of academic impact, for papers by Peihua Lu Breakdown of academic impact, for papers by Colleen Callahan Breakdown of academic impact, for papers by Anthony F. Daniyan Breakdown of academic impact, for papers by Quanshun Wang Breakdown of academic impact, for papers by Margherita Norelli Breakdown of academic impact, for papers by Corinne Summers Breakdown of academic impact, for papers by Reona Sakemura Breakdown of academic impact, for papers by Christopher Brown
Rankless by CCL
2026